This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2016 Jun 15;79(12):948-9.

doi: 10.1016/j.biopsych.2016.02.016.

Evaluating New Pharmacotherapies for Schizophrenia

William T Carpenter¹

Affiliations

Affiliation

¹ Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: wcarpent@mprc.umaryland.edu.

PMID: 27240999
DOI: 10.1016/j.biopsych.2016.02.016

Comment

Evaluating New Pharmacotherapies for Schizophrenia

William T Carpenter. Biol Psychiatry. 2016.

. 2016 Jun 15;79(12):948-9.

doi: 10.1016/j.biopsych.2016.02.016.

Author

William T Carpenter¹

Affiliation

¹ Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland. Electronic address: wcarpent@mprc.umaryland.edu.

PMID: 27240999
DOI: 10.1016/j.biopsych.2016.02.016

No abstract available

PubMed Disclaimer

Comment on

ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial.
Lieberman JA, Davis RE, Correll CU, Goff DC, Kane JM, Tamminga CA, Mates S, Vanover KE. Lieberman JA, et al. Biol Psychiatry. 2016 Jun 15;79(12):952-61. doi: 10.1016/j.biopsych.2015.08.026. Epub 2015 Aug 31. Biol Psychiatry. 2016. PMID: 26444072 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information